GHK-Cu, the glycyl-histidyl-lysine tripeptide complexed with copper, is studied for its activity in skin, tissue-remodelling and regenerative research models
Market Expansion & Competition Rival GLP-1 pills are in late-stage development, including Eli Lillys orforglipron , which could be approved in 2026
10.1016/j.lfs.2019.116940 121 WangP.PeskoeS.ByrdR.SmithP.BreslinR.ChowS
tefan M, Kiss B, Gutleb A, Loghin F (2020) Redox metabolism modulation as a mechanism in SSRI toxicity and pharmacological effects
doi: 10.3389/fmicb.2025.1685962 Received 28 August 2025 Accepted 27 October 2025 Published 12 November 2025 Volume 16 - 2025 Edited by Vikash Kumar, Central Inland Fisheries Research Institute (ICAR), India Reviewed by Sijie Wang, Affiliated Hospital of Guangdong Medical College Hospital, China Xuchang Zhou, The First Affiliated Hospital of Xiamen University, China Updates Copyright 2025 Wang, Xu, Zha and Wu
Those that did coaching paired with GLP-1s agonist for one year observed an average 15.6% weight loss
